Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313406750> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4313406750 endingPage "447" @default.
- W4313406750 startingPage "441" @default.
- W4313406750 abstract "Aim: To explore the clinical value of magnetic resonance imaging (MRI) combined with serum prostate specific antigen (PSA), epithelial cadherin (sE-cadherin) and early prostate cancer antigen-2 (EPCA-2) in prostate cancer (PC) diagnosis. Patients and Methods: Fifty patients with PC and 50 with benign prostatic hyperplasia (BPH) confirmed by pathology from January 2020 to July 2021 were studied retrospectively. All patients underwent MRI and measurement of the serum levels of PSA, EPCA-2, and sE-cadherin. The diagnostic accuracy and efficacy of these methods was compared between the groups. Results: In MRI diagnosis of PC, lesions were mainly located in the peripheral zone; T2-weighted imaging of this zone showed low signal intensity, with different degrees of prostate enlargement. BPH had a clear boundary, complete capsule and central zone hyperplasia and uneven signal nodules. PC and BPH had different degrees of prostate enlargement. Serum levels of PSA, sE-cadherin and EPCA-2 in the cancer group were significantly higher than those in the BPH group (p<0.05). The diagnostic concordance of combined assessment of MRI, PSA, sE-cadherin, and EPCA-2 in differentiating PC from BPH was 93%, which was significantly higher than these approaches used alone (84%, 79%, 81% and 82%, respectively; p<0.05). The area under the receiver operating characteristics curve for the combined approach in PC diagnosis was 0.900, which was significantly higher than those for the individual methods (0.840, 0.730, 0.760 and 0.810, respectively; Z=2.343, p=0.004). Conclusion: MRI combined with PSA, sE-cadherin and EPCA-2 can improve the sensitivity and accuracy of PC diagnosis and has potential as a guiding scheme for early diagnosis of PC." @default.
- W4313406750 created "2023-01-06" @default.
- W4313406750 creator A5000361082 @default.
- W4313406750 creator A5018370210 @default.
- W4313406750 creator A5032379172 @default.
- W4313406750 creator A5036990231 @default.
- W4313406750 creator A5038304820 @default.
- W4313406750 creator A5044312591 @default.
- W4313406750 creator A5090746432 @default.
- W4313406750 date "2022-12-30" @default.
- W4313406750 modified "2023-09-25" @default.
- W4313406750 title "Clinical Value of Magnetic Resonance Imaging Combined With Serum Prostate-specific Antigen, Epithelial Cadherin and Early Prostate Cancer Antigen 2 In Diagnosis of Prostate Cancer" @default.
- W4313406750 doi "https://doi.org/10.21873/anticanres.16180" @default.
- W4313406750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36585192" @default.
- W4313406750 hasPublicationYear "2022" @default.
- W4313406750 type Work @default.
- W4313406750 citedByCount "0" @default.
- W4313406750 crossrefType "journal-article" @default.
- W4313406750 hasAuthorship W4313406750A5000361082 @default.
- W4313406750 hasAuthorship W4313406750A5018370210 @default.
- W4313406750 hasAuthorship W4313406750A5032379172 @default.
- W4313406750 hasAuthorship W4313406750A5036990231 @default.
- W4313406750 hasAuthorship W4313406750A5038304820 @default.
- W4313406750 hasAuthorship W4313406750A5044312591 @default.
- W4313406750 hasAuthorship W4313406750A5090746432 @default.
- W4313406750 hasConcept C121608353 @default.
- W4313406750 hasConcept C126322002 @default.
- W4313406750 hasConcept C126838900 @default.
- W4313406750 hasConcept C126894567 @default.
- W4313406750 hasConcept C142724271 @default.
- W4313406750 hasConcept C143409427 @default.
- W4313406750 hasConcept C147483822 @default.
- W4313406750 hasConcept C203014093 @default.
- W4313406750 hasConcept C2776235491 @default.
- W4313406750 hasConcept C2777562237 @default.
- W4313406750 hasConcept C2780192828 @default.
- W4313406750 hasConcept C2781406297 @default.
- W4313406750 hasConcept C58471807 @default.
- W4313406750 hasConcept C71924100 @default.
- W4313406750 hasConceptScore W4313406750C121608353 @default.
- W4313406750 hasConceptScore W4313406750C126322002 @default.
- W4313406750 hasConceptScore W4313406750C126838900 @default.
- W4313406750 hasConceptScore W4313406750C126894567 @default.
- W4313406750 hasConceptScore W4313406750C142724271 @default.
- W4313406750 hasConceptScore W4313406750C143409427 @default.
- W4313406750 hasConceptScore W4313406750C147483822 @default.
- W4313406750 hasConceptScore W4313406750C203014093 @default.
- W4313406750 hasConceptScore W4313406750C2776235491 @default.
- W4313406750 hasConceptScore W4313406750C2777562237 @default.
- W4313406750 hasConceptScore W4313406750C2780192828 @default.
- W4313406750 hasConceptScore W4313406750C2781406297 @default.
- W4313406750 hasConceptScore W4313406750C58471807 @default.
- W4313406750 hasConceptScore W4313406750C71924100 @default.
- W4313406750 hasIssue "1" @default.
- W4313406750 hasLocation W43134067501 @default.
- W4313406750 hasLocation W43134067502 @default.
- W4313406750 hasOpenAccess W4313406750 @default.
- W4313406750 hasPrimaryLocation W43134067501 @default.
- W4313406750 hasRelatedWork W2023601918 @default.
- W4313406750 hasRelatedWork W2038565121 @default.
- W4313406750 hasRelatedWork W2074491453 @default.
- W4313406750 hasRelatedWork W2273540743 @default.
- W4313406750 hasRelatedWork W2390043372 @default.
- W4313406750 hasRelatedWork W2463544891 @default.
- W4313406750 hasRelatedWork W2897445903 @default.
- W4313406750 hasRelatedWork W3047346330 @default.
- W4313406750 hasRelatedWork W3129209394 @default.
- W4313406750 hasRelatedWork W4281788288 @default.
- W4313406750 hasVolume "43" @default.
- W4313406750 isParatext "false" @default.
- W4313406750 isRetracted "false" @default.
- W4313406750 workType "article" @default.